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Introduction: Spirometry may reveal pre-clinical abnormal airway function in asymptomatic
subjects and allow a better definition of severity in clinically diagnosed asthma and COPD.
The hypothesis of this study was that telespirometry might increase the diagnostic accuracy
of asthma and COPD.
Methods: In the Italian ‘‘Alliance’’ study, 638 general practitioners (GPs) were trained to
perform telespirometry and were asked to enrol the following categories of subjects: (a)
current or ex-smokers without respiratory symptoms; (b) subjects with respiratory symptoms
but without a pre-existing diagnosis of asthma or COPD; (c) subjects with a pre-existing clinical
diagnosis of asthma; and (d) subjects with a pre-existing clinical diagnosis of COPD. Subjects
completed a case report form (CRF) and performed telespirometry in the GP’s office. Traces
were sent by telephone to a Telespirometry Central Office, where they were interpreted by
a pulmonary specialist, according to appropriately defined criteria. The results were returned
in real time to the GP.restricted grant from AstraZeneca, Italy.
Unit, Hospital of Bergamo, Bergamo, Italy. Tel.: þ39 035 269 714; fax: þ39 035 266 825.
niti.bergamo.it (A. Rossi).
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Office spirometry and airflow obstruction in primary care 867Results: Overall, 9312 subjects were recruited and 7262 (78%) performed an acceptable tele-
spirometric examination and the CRF. In the asymptomatic group, 340/1437 (24%) of the tele-
spirometries were abnormal (147 with moderate-to-severe airway obstruction, i.e. FEV1 <80%
of predicted). Among symptomatic subjects, 1433/3725 (38%) had abnormal telespirometries
(682 with moderate-to-severe obstruction). Of the asthmatic subjects, 336/1285 (26%) had
moderate-to-severe airway obstruction, while telespirometry was normal in 184/815 (23%)
of the COPD group.
Conclusion: Telespirometry, performed in a GP’s office, can aid the diagnosis of obstructive
airway diseases and could help GPs to better manage airway obstruction.
ª 2008 Elsevier Ltd. All rights reserved.Introduction
Obstructive airway diseases such as asthma and chronic
obstructive pulmonary disease (COPD) are a major medical
problem.1 Both are associated with an inflammatory
disorder of the airways.2,3 Spirometry can reveal abnormal
airway function well before the full clinical manifestations
of COPD.4,5 Also in asthma lung function can be abnormal in
asymptomatic subjects. Spirometry can also help to assess
whether asthma is adequately controlled.6 Furthermore,
abnormal spirometric findings are marker of increased risk
of premature death from any cause.7 The early diagnosis of
airway disease might help affected people and caregivers
to take some effective preventive measures such as
allergen avoidance, adhesion to smoking cessation
programs,8 and adoption of a healthier lifestyle.4 In addi-
tion, once a diagnosis of an obstructive airway disease such
as asthma or COPD has been made, effective treatments
can be offered to the patients.2,3,9
Unfortunately, spirometry has failed to penetrate into
the mainstream of clinical practice.7 However, given the
high incidence of obstructive airway diseases in the general
population, the use of diagnostic tools, such as office
spirometry, in the primary care setting cannot be dis-
missed. While simple measurements of peak flow cannot
substitute spirometry either for detecting airway obstruc-
tion or for determining its severity,10e12 diagnostic
spirometry in a hospital-based lung function laboratory is
expensive and the financial resources for examining the
large population of subjects with suspected airway diseases
in this setting are not available.
Office spirometry has been implemented in general
practice, with the aim to perform a pre-clinical diagnosis of
chronic airway obstruction in subjects at risk, with con-
flicting results.13 Two recent documents from the American
College of Physician (ACP) stated that ‘‘spirometry should
not be used for screening in asymptomatic individuals’’.9,14
On the other hand, the GOLD document suggests that ‘‘a
clinical diagnosis of COPD should be considered in any
patient who has a history of exposure to risk factors for the
disease; the diagnosis should be confirmed by spirom-
etry’’.2 Clearly the latter statement2 indicates a much
wider use of spirometry than the former,9 with important
implications for its implementation in primary care.
This paper reports the results of an Italian study on the
feasibility and usefulness of telespirometry in general
practice. The study, named ‘‘Alliance’’ to denote the link
between pulmonary specialists and GPs in the managementof airway obstructive diseases, involved a large number of
GPs under the supervision of selected pulmonary special-
ists. The aims of this project were: (a) to improve the
familiarity of GPs with spirometry; and (b) to demonstrate
the usefulness of a spirometric evaluation in selected
subjects with risk factors only or the presence of respira-
tory symptoms and/or a clinical diagnosis of obstructive
airway disease, in the primary care setting. Telespirometry
was chosen as a innovative tool whereby GPs had some
interaction with the pulmonary specialist located in the
central laboratory in which the telespirometric data were
analysed.15,16
The hypothesis was that telespirometry may detect
airway obstruction in subjects with risk factors or symptoms
of chronic airway disease, and may improve the assessment
and management of patients with clinical diagnosis of
asthma and COPD, in general practice. At the present time,
no data about the usefulness of telespirometry in large
number of subjects recruited in general practice has been
published.
Methods
Study protocol
This was an observational study, involving a large sample of
GPs from all regions of Italy. Fifty-one pulmonary units
distributed throughout the country were asked to partici-
pate in the study. In each centre, a pulmonary specialist
provided the education and training to a group of 20 GPs
selected according to their willingness to perform
telespirometry.
A Steering Committee defined the study design and
identified the 51 pneumology units. Educational material on
asthma, COPD and spirometry was prepared for the first
teaching session. In each pulmonary unit, a 6-h educational
session was conducted with the 20 selected GPs: the topics
were the diagnosis of asthma and COPD, the technique for
performing spirometry and telespirometry, and the
presentation of the study design.
The GPs could perform telespirometry in her/his
general practice, in any subjects. Furthermore each GP
was asked to select, from the general practice, subjects
with known or suspected chronic airway disease, and to
record their data on case report form (CRF). Each GP was
equipped with a simple, portable pneumotachograph
(Spirotel, MIR, Roma, Italy) to measure the main indices
derived from a maximal forced expiratory manoeuvre, and
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Central Office, TCO (ITMS: International TeleMedicine
Service, Genoa, Italy). After obtaining by the patient an
informed consent, GPs performed simple spirometry (at
least three blows in the Spirotel) and sent by telephone all
tracings to the TCO. In real time, a connection was
established by telephone with the operator of the TCO who
commented on the quality of the spirometric traces,
invited the GP to perform additional expiratory manoeu-
vres in the same subjects, and offered an interpretation of
the results of the single patient. Then, the report was sent
by fax to the GP’s office.
The criteria used to assess the acceptability of a single
expiratory manoeuvre were: time to peak flow < 150 msec,
back extrapolation < 5% FVC (or 150 ml), lack of cough
during expiration, expiratory time  3 s, and end-expira-
tory flow < 0.2 l/s. The criteria used to accept a single
telespirometric test were the presence of two at least
acceptable and reproducible manoeuvres. Reproducibility
was defined as a difference in FEV1 and in FVC between two
manoeuvres of less than 5% and less than 200 ml.
Subjects with abnormal telespirometry and without
previous spirometric records were invited to repeat
a spirometry in the local pulmonary unit, but no attempt to
collect these data was done.
Diagnostic criteria
For the purpose of this study, only the following interpre-
tation criteria were considered: FEV1/FVC  0.7 and FEV1 
80% of predicted signified normal spirometry; FEV1/FVC <
0.7 signified airflow obstruction (mild: FEV1  80% of pre-
dicted; moderate: FEV1 <80% and  50% of predicted;
severe: FEV1 < 50% and  30% of predicted; very severe:
FEV1 < 30% of predicted); FEV1/FVC  0.7 and FEV1 < 80%
of predicted signified abnormal telespirometry, but not
clear airflow obstruction. FEV1/FVC fixed ratio, and not
FEV1/VC% predicted, was used to assess for the presence of
airway obstruction, according to ACCP, GOLD and ATS/ERS
Guidelines. Other minor changes in telespirometry traces
were not included in the group of patients with airflow
obstruction. For the purpose of this study, telespirometric
examinations in which only FEV1 could be measured were
considered not acceptable. In the statistical analysis,
patients with severe and very severe airway obstruction
were grouped together.Table 1 Distribution of the population among the four inclusio
and telespirometric results.
Current or ex-smokers Sy
Cases 1816 (100%) 48
Age (meanSD) 49 (13.3)
Male/female (%) 68/32 55
Smoker/ex-smoker (%) 88/12 33
Acceptable spirometries 1437 (79%) 37
Normal 1097 (76%) 22
Obstructed 245 (17%) 9
Abnormal, but not clearly obstructed 95 (17%) 4
Not acceptable 379 (21%) 11Subjects
Each GP was asked to enrol, from his/her general practice
(i.e. from the people attending the GP’s office for any
reason), the following categories of subjects: (1) current or
ex-smokers without respiratory symptoms; (2) subjects with
respiratory symptoms e such as wheezing, chest tightness,
chronic cough with or without phlegm, any kind of dyspnoea
e but without a pre-existing diagnosis of asthma or COPD; (3)
subjects with a pre-existing clinical diagnosis of bronchial
asthma; and (4) subjectswith a pre-existing clinical diagnosis
of COPD. The recruited subjects were asked to perform
a telespirometry test in the GP’s office, under the direction
of their GP. The individual data, including sex, age, anthro-
pometric data, smoking habits, symptoms, previous diag-
nosis of asthma or COPD, and telespirometry results, were
collected in a case report form (CRF).
Statistical analysis
All CRF data were entered into a specific computerised
system separately by the general pulmonary telemedicine
data base. The telespirometry results were processed for
the whole population of the recruited subjects as well as
for the different groups. The variables were analysed using
standard procedures depending on the underlying distri-
bution. Descriptive statistics, consisting of numbers and
percentages for ordinal and categorical variables and
means with standard deviations or medians with ranges for
continuous variables and valid cases, are presented.
Results
Six hundred and thirty-eight (638) GPs collected both tel-
espirometries and clinical data on a CRF in subjects
attending to their clinic. Overall, 9312 subjects completed
both the CRF and the spirometric tests in the GP’s office.
For 7262 of these subjects (78%), the spirometric tests were
classified as acceptable by the ITMS specialists. According
to the inclusion criteria, the subjects were divided into the
four previously described groups (Table 1).
Out of the 7262 subjects who provided spirometric
traces acceptable for evaluation, 59% were considered
normal, whereas 41% (3003 subjects) exhibited an
abnormal spirometric pattern: 2159 subjects (30%)n categories together with mean age, gender, smoking habits
mptomatic patients Asthmatics COPD Total
77 (100%) 1636 (100%) 983 (100%) 9312 (100%)
55 (16.1) 47 (16.9) 68 (10.3) 55 (9.5)
/45 46/54 74/26 58/42
/26 22/21 27/50 41/25
25 (76%) 1285 (79%) 815 (83%) 7262 (78%)
92 (62%) 686 (53%) 184 (23%) 4259 (59%)
46 (25%) 430 (34%) 538 (66%) 2159 (30%)
87 (13%) 169 (13%) 93 (11%) 844 (11%)
52 (24%) 351 (21%) 168 (17%) 2050 (22%)
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subjects (11%) had abnormal results which were not
interpreted as indicating airway obstruction because the
low FEV1 (<80% of predicted) was associated with a FEV1/
FVC  0.7. Among the group of asymptomatic smokers/
ex-smokers, 340 subjects (24% of this group) had
abnormal telespirometric results. Also 1433 symptomatic
subjects (38%) produced abnormal results. On the other
hand, 686 subjects in the asthma group (53%) and 184
subjects in the COPD group (23%) exhibited normal
spirometry at the time of the test.
From Table 1 it can be seen that the proportions of non-
acceptable tests and of non-obstructive patterns did not
vary between the groups. In contrast, the percentage of
normal tests decreased progressively while the percentage
of obstructive abnormalities increased progressively from
the current/ex-smokers group to the symptomatic, asth-
matic, and COPD groups.
Figure 1 shows the percent distribution of the severity of
airway obstruction in all spirometric tests with an
obstructive pattern. From the total 2159 subjects with
some degree of obstructive spirometric abnormality, 520
(24%) had mild obstruction, 1029 (48%) had moderate
obstruction and 610 (28%) had severe or very severe airflow
obstruction. Two hundred and forty-five (245) subjects with
airflow obstruction did not report any symptom or clinical
diagnosis and were asymptomatic smokers/ex-smokers; of
these subjects, 147 (i.e. 10% of the whole group) already
had moderate-to-severe obstruction. In the group of
subjects with respiratory symptoms, 682/3725 subjects
(18%) had moderate- to- severe airflow obstruction.
Among the 1285 subjects with a pre-existing diagnosis of
asthma and acceptable telespirometric traces, 336 (26%)
had moderate or severe airflow obstruction. The others had
either normal spirometry (53%), mild airflow obstruction
(7%) or abnormal spirometric results that were not diag-
nostic of airway obstruction (13%). Among patients with
a pre-existing clinical diagnosis of COPD, 474 subjects (58%
of those with acceptable spirometric traces) had moderate
or severe airflow obstruction (239 and 235 subjects,
respectively). Sixty-four subjects (12% of the obstructed
subjects in the COPD group) had a mild obstructive pattern.
Therefore 23% of patients in this group had a clinical
diagnosis of COPD but normal telespirometry.0
20
40
60
80
100
120
Current or ex-
smokers
Symptomatic
patients
Asthmatics COPD
Mild Obstruction Moderate Obstruction Severe Obstruction
Figure 1 Distribution of spirometric results with an
obstructive pattern among the four inclusion categories.The percentage of subjects who reported to have
already performed a spirometry in a laboratory was 40,2%
(23,5% of the current or ex -smokers group patients, 30,3%
of the symptomatic group patients, 66,4% of the asthma
group patients and 76,3% of the COPD group patients). In
general, GPs have no data about the results of these
previous spirometries.Discussion
The results of this study show that telespirometry in the
primary care setting can demonstrate spirometric abnor-
malities and detect airflow limitation in subjects without
chronic respiratory symptoms but at risk of COPD because
of smoking habits. These data support the statement in the
GOLD document2 and cast doubts on the strategy of denying
spirometry to individuals without respiratory symptoms,
although exposed to risk, as suggested by the ACP docu-
ments.9,14 On the other hand, our study also shows that
asthma severity may be better defined in subjects with
a clinical diagnosis of asthma, and that a significant
proportion of patients with a clinical diagnosis of COPD had
spirometric values within the normal limits (23%) and were,
therefore, labelled with a wrong diagnosis.
In our study, 78% of the examined population performed
an acceptable test, according to pre-established criteria, in
the GPs’ office, and the specialists at the ITMS were,
therefore, able to interpret the results. Previous studies
reported a similar rate of successful spirometric tests which
met the ATS criteria of acceptability.4,17e21 Although the
acceptability criteria we used were slightly different from
ATS criteria,13 in our study the pulmonary specialist at the
ITMS centre was in continuous communication with the GPs
for each spirometric test. The success rate of spirometric
examinations varies between hospital-based studies and
general practice-based studies.22 The rate of acceptable
spirometric tests can be improved if the tests are per-
formed under the supervision of trained technicians rather
than by the GPs. However, in this study, the willingness of
the GPs to perform the telespirometry directly in their
offices allowed the recruitment of a very large number of
subjects.
Our results, on a large number of subjects, suggest that
office telespirometry canprovideuseful clinical information.
In fact, in our population of more than 7000 subjects for
whom both CRF data and acceptable spirometry traces were
available, airflow obstruction was found in more than 2000
subjects, almost 30% of that population. A similar prevalence
was found in a large survey in Poland, in which 25% of over
11,000 tested subjects had some degree of airflow obstruc-
tion.23 In that study, about 9%of the subjects hada lowFVC.23
In our study the prevalence of a ‘‘restrictive’’ pattern was
comparable, being 11.6%. These abnormalities were not
diagnosed as real restrictive pathology because of the lack of
measurement of lung volumes.24 In the Dutch study, the
prevalence of airflow obstruction was 18% among 554
subjects with ATS-acceptable spirometry.19 In this study, we
used the fixed cut-off value of FEV1/FVCZ 0.7, belowwhich
the test was considered to demonstrate airflow obstruction.
Although there is a large debate about this issue,25 we made
this decision following the indication of the international
870 G. Averame et al.guidelines.2,26 Clearly, it cannot be excluded that there is
a greater risk of misclassification with office spirometry in
the primary care setting than in hospital-based laborato-
ries.22 However, office spirometry remains the only possi-
bility for screening and case-finding studies in large numbers
of subjects.27 The cost-effectiveness of this early detection
of airway obstruction was not evaluated in this study, but it
could be an important end point in future studies.
In a recent study, Lamprecht and colleagues28 used the
forced expiratory volume in 6 s (FEV6) as a surrogate for the
FVC and suggested that a FEV1/ FEV6 <0.7 should be
accepted as a parameter of airflow obstruction only when
the FEV1 is <80% of predicted. In our study, 1639 subjects
exhibited moderate-to-severe airflow obstruction because
the FEV1 was <80% of predicted. In other words, 22.6% of
the whole population with evaluable spirometric traces had
significant airflow obstruction according to the criteria
proposed by Lamprecht and colleagues.28 About 50% of
these patients with obstruction, i.e. 810 subjects, had
a pre-existing clinical diagnosis of asthma or COPD but the
other 50% were asymptomatic current/ex-smokers or
complained of some respiratory symptoms without a diag-
nosis. Therefore, office telespirometry performed by GPs in
the primary care setting revealed 829/5162 subjects (16% of
the total) with previously unknown significant airflow
obstruction (Table 1). In the Polish survey on 11,000
smokers, the prevalence of mild airflow obstruction was
10%, that of moderate obstruction 10% and that of severe
airflow obstruction 5%.23 In the DIDASCO study, only 4% of
subjects with no complaints had a spirometric pattern
indicating airflow obstruction.29 The result of our study is of
particular interest because relatively healthy subjects in
their 50s are unlikely to see their GP even if they are
smokers.4 Our results, therefore, support the recommen-
dation from GOLD guidelines that smokers (and ex-smokers)
over 45 years old should be encouraged to perform
spirometry among other health tests. The demonstration of
some airflow obstruction could improve adherence to
a smoking cessation program, which is an effective measure
for slowing down the accelerated decline in FEV1 that leads
to disability and death.2,4,8,23,30 There are, however,
dissenting opinions on this issue,31 questioning the useful-
ness of early detection of COPD.14 However, in the Polish
study,23 two-thirds of the participants returned for the
follow-up 12 months later.32 Half of them had airflow
obstruction according to the first examination. The rate of
smoking cessation among the subjects with airflow
obstruction was double that among the subjects without
compromised spirometry.8,32 A recent study on 561 current
smokers underwent spirometry to compute their lung age.
The rate of smoking cessation was almost doubled in
smokers who were told their lung age.32 These data support
the conclusion that the results of spirometric tests are
useful and that screening and case-finding programs for
COPD using office spirometry help the success of social
programs.
This study is the first to have been conducted on a pop-
ulation large enough to allow analysis of sub-groups.
Despite having similar aims, previous studies were on much
smaller populations and had different designs.17,18,29
In the group of subjects with a pre-existing diagnosis of
bronchial asthma, almost 50% had abnormal spirometry:336 subjects (26%) had moderate-to-severe obstruction.
Office spirometry can aid the management of airway
obstruction in patients with asthma who present to their
GP’s office with respiratory symptoms.33 Although normal
spirometric results do not rule out asthma, they suggest
that the disease is probably adequately controlled. On the
other hand, abnormal spirometric findings can indicate that
therapy is insufficient. Furthermore, almost 22% of the
asthmatics in our study are current smokers. It is known
that some asthmatics smoke despite their asthma and that
cigarette smoking decreases the sensitivity to pharmaco-
logical treatment.34,35 Objective demonstration of airflow
obstruction should help to convince asthmatics to quit
smoking as early as possible.
In the group of subjects with a pre-existing ‘‘clinical’’
diagnosis of COPD, office telespirometry confirmed that
diagnosis in more than 60% of them. In a relatively small
group of subjects (11%), the spirometric test could not be
classified as demonstrating a restrictive disorder thus sug-
gesting the need for additional investigations to amend or
confirm the initial diagnosis. On the other hand, a signifi-
cant proportion of subjects (23%) had normal spirometric
findings at the time of the study. Clearly this result shows
that those subjects were misdiagnosed: in fact, COPD is
a fixed, not fully reversible airflow obstruction.2 This point
may have relevant consequences as regards an undue
overtreatment in these non-obstructed patients with
a ‘‘clinical’’ diagnosis of COPD.
Our study has some limitations. First, we used the fixed
FEV1/FVC ratio for the diagnosis of airflow obstruction. It has
been well documented that this approach may classify
wrongly the prevalence of airflow obstruction compared to
other criteria.36 However, we found that a significant
proportion of subjects, even among asymptomatic smokers/
ex-smokers, had a FEV1/FVC <0.7 associated with a FEV1
<80% of predicted. We share the view of Lamprecht and
colleagues28 that this association should not be neglected
and has clinical relevance. Second, the subjects examined in
this study were not selected randomly from a general pop-
ulation, but they represented a very selected group of
subjects, according to the choice of the GPs. This may limit
the validity of our data for extrapolation to the general
population. However, the large number of examined
subjects may reduce the relevance of such a limitation.
Third, no data on the results of a previous or following
spirometry performed in laboratory by the same subjects
(particularly in subjects with no typical airway obstruction)
were available, although subjects with telespirometric
abnormalities were encouraged to repeat a spirometry in
laboratory. Fourth, the mean number of subjects examined
by each GP in the study period was small, however with
a large variability, and therefore we cannot conclude defi-
nitely that telespirometrymay be performed routinely in the
clinical practice. However we showed the feasibility and the
possible usefulness of telespirometry in the assessment of
obstructive airway diseases in primary care.
In conclusion, this study recruited a large population of
subjects, distributed across the nation, who visited their
GPs for various reasons. The results show that office tele-
spirometry can provide useful clinical information which
can be exploited immediately by the GP for diagnostic and
clinical management decisions. When appraising the results
Office spirometry and airflow obstruction in primary care 871of office telespirometry, it should be taken into account
that the high prevalence of obstructive airway diseases in
the general population makes it necessary that interven-
tions are delivered in the primary care setting. Office tel-
espirometry is one way to ensure that interventions are
based on objective measures, albeit with some limitations,
and not only on a doctor’s clinical impression or a patient’s
subjective symptoms.
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